Operates Davaindia generic-pharmacy retail chain plus domestic pharma marketing and export drug manufacturing.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 25 | 25 | 25 | 25 | 26 | 29 | 31 | 35 |
| Reserves | 44 | 42 | 64 | 55 | 64 | 195 | 285 | 659 |
| Borrowings | 0 | 0 | 15 | 45 | 95 | 140 | 181 | 270 |
| Other Liabilities | 20 | 19 | 35 | 33 | 43 | 76 | 109 | 167 |
| Total Liabilities | 88 | 85 | 139 | 158 | 228 | 439 | 606 | 1.1k |
| AssetsFixed Assets | 15 | 14 | 29 | 62 | 103 | 185 | 251 | 383 |
| CWIP | 0 | 0 | 0 | 3 | 5 | 6 | 7 | 2 |
| Investments | 14 | 10 | 33 | 8 | 5 | 54 | 92 | 264 |
| Other Assets | 59 | 61 | 77 | 85 | 116 | 193 | 256 | 483 |
| Total Assets | 88 | 85 | 139 | 158 | 228 | 439 | 606 | 1.1k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -3 | 6 | -1 | 13 | -2 | -6 | -50 | -84 |
| Cash from Investing | 9 | -4 | 4 | -27 | 15 | -13 | -92 | -314 |
| Cash from Financing | -6 | -3 | -2 | 14 | -14 | 19 | 145 | 490 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -6 | -1 | -2 | 10 | -13 | -23 | -96 | -197 |
| FCF Margin | — | — | — | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
ZOTA · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.